Sign in

CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(919) 636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,310,718
in 4 filings, $1.2M under 10b5-1 plans

Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Andrade Robert −$884K CHIEF FINANCIAL OFFICER sold 26% of stake
  2. Brughera Marco Maria −$160K Director sold 100% of stake
  3. Sayad Pierre Sargis −$146K Chief Medical Officer sold 56% of stake
  4. Raykov Rosty −$121K Former Director sold 7% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-02 Raykov Rosty Director Option exercise · Stock Options 10b5-1 −15,598 $2.45 $38K 1,587,390
2026-02-28 Raykov Rosty Director Grant or award 10b5-1 +5,208 109,204
2026-02-28 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +1,191 243,584
2026-02-18 Hackman Jeffrey S. Chief Executive Officer Option exercise +13,710 28,710
2026-02-18 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise +2,450 $4.08 $10K 215,108
2026-02-18 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise +27,285 242,393
2026-02-18 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise · Stock Options −2,450 $4.08 $10K 814,117
2026-02-02 Raykov Rosty Director Option exercise 10b5-1 +15,598 $2.45 $38K 108,826
2026-02-02 Raykov Rosty Director Sale 10b5-1 −10,349 $7.76 $80K 98,477
2026-02-02 Raykov Rosty Director Option exercise · Stock Options 10b5-1 −15,598 $2.45 $38K 1,602,988
2026-01-31 Raykov Rosty Director Grant or award +5,208 93,228
2026-01-31 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +1,558 212,658
2026-01-23 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise +10,000 $2.45 $25K 211,100
2026-01-23 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise · Stock Options −10,000 $2.45 $25K 816,567
2026-01-15 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise +10,000 $2.45 $25K 201,100
2026-01-15 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise · Stock Options −10,000 $2.45 $25K 826,567
2026-01-07 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise +14,184 $2.45 $35K 191,100
2026-01-07 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise · Stock Options −14,184 $2.45 $35K 836,567
2026-01-02 Raykov Rosty Director Option exercise 10b5-1 +15,598 $2.45 $38K 98,332
2026-01-02 Raykov Rosty Director Sale 10b5-1 −10,312 $7.60 $78K 88,020

Page 6 of 8 · 159 trades